PROVIDER PROFILE · NPI 1659355691

Dennis HilliardM.D.

Hematology-OncologySan Bernardino, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

223

Distinct HCPCS

Medicare payment

$15K

Peer benchmark

Total Medicare services vs. 957 Hematology-Oncology providers in CA — above median (cohort median 4,173).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$250K

Distinct drugs

Brand share

22.8%

Top prescribed drugs

Anastrozole30 claims

Dexamethasone14 claims

Nilotinib Hcl13 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$2K

Education$12

Top paying entities

Food and Beverage$2K

Education$12

REFERRAL NETWORK

Where Dennis Hilliard's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Unilab Corporation Clinical Laboratory · West Hills, CA	114	1,242
REDLANDS COMMUNITY HOSPITAL	30	141
Kimberly Bluff Nurse Practitioner · Loma Linda, CA	22	138
Unilab Corporation Clinical Laboratory · Highland, CA	16	88
SEVENTH-DAY ADVENTISTS LOMA LINDA UNIVERSITY MEDICAL CENTER	14	150
Dale Broome Diagnostic Radiology · Redlands, CA	12	56
Rajiv Malik Hematology-Oncology · San Bernardino, CA	11	44

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history